Published in Dig Dis Sci on November 01, 1985
Overview of misoprostol clinical experience. Dig Dis Sci (1986) 0.89
Effects of misoprostol on gastric acid and mucus secretion in man. Dig Dis Sci (1986) 0.84
Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution? Drugs (1990) 0.78
Overview of clinical safety with misoprostol. Dig Dis Sci (1985) 0.75
Novel mechanisms and signaling pathways of esophageal ulcer healing: the role of prostaglandin EP2 receptors, cAMP, and pCREB. Am J Physiol Gastrointest Liver Physiol (2014) 0.75
Healing of duodenal ulcer with an antacid regimen. N Engl J Med (1977) 3.32
Cimetidine in patients with gastric ulcer: a multicentre controlled trial. Br Med J (1977) 2.08
Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration. Gastroenterology (1976) 1.54
Cimetidine in the treatment of gastric ulcer: review and commentary. Gastroenterology (1978) 1.30
Cimetidine, antacid, and hospitalization in the treatment of benign gastric ulcer: a multicenter double blind study. Gastroenterology (1978) 1.30
Gastric and duodenal ulcer healing under placebo treatment. Gastroenterology (1977) 1.23
Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial. N Engl J Med (1983) 1.10
Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs. J Pharmacol Exp Ther (1979) 1.08
Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion. Dig Dis Sci (1983) 1.04
SC-29333: a potent inhibitor of canin gastric secretion. Am J Dig Dis (1976) 1.04
Effects of E prostaglandins on canine gastric potential difference. Am J Dig Dis (1978) 1.03
The cytoprotective effects of (+/-)-15-deoxy-16-alpha, beta-hydroxy-16-methyl PGE1 methyl ester (sc-29333) versus aspirin-shock gastric ulcerogenesis in the dog. Prostaglandins (1981) 0.94
Peptic ulcer: new therapies, new diseases. Ann Intern Med (1981) 0.90
Effect of SC-29333, an inhibitor of gastric secretion, on canine gastric mucosal blood flow and serum gastrin levels. Arch Int Pharmacodyn Ther (1978) 0.87
Healing of gastric ulcers after one, two, and three months of ranitidine. Br Med J (Clin Res Ed) (1982) 0.86
Peptic ulcer. Dis Mon (1981) 0.75
Drug therapy for peptic ulcer: drugs that act on the gastric mucosa. J Clin Gastroenterol (1981) 0.75
Problems of interpretation in secondary prevention trials in coronary heart disease. Med J Aust (1977) 0.75
Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet (1988) 10.82
Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med (1974) 2.46
Safety of cimetidine. Gastroenterology (1978) 1.34
Cimetidine, antacid, and hospitalization in the treatment of benign gastric ulcer: a multicenter double blind study. Gastroenterology (1978) 1.30
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol (2000) 1.28
Endoscopic removal of a toothbrush. Gastrointest Endosc (1983) 1.25
Evaluation of therapeutic options for pancreatic pseudocysts. Arch Surg (1982) 1.16
Gastrin and somatostatin secretion by perfused rat stomach: functional linkage of antral peptides. Am J Physiol (1980) 1.15
Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs. J Pharmacol Exp Ther (1979) 1.08
Comparative study of secretin and Lundh tests. Am J Dig Dis (1975) 1.08
Loperamide binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1976) 1.06
Chemistry and synthetic development of misoprostol. Dig Dis Sci (1985) 1.05
SC-29333: a potent inhibitor of canin gastric secretion. Am J Dig Dis (1976) 1.04
Effects of E prostaglandins on canine gastric potential difference. Am J Dig Dis (1978) 1.03
The liver in secondary syphilis. South Med J (1982) 1.03
Stimulation of gastrin and somatostatin secretion from the isolated rat stomach by bombesin. Am J Physiol (1981) 1.02
Upper gastrointestinal endoscopy in normal asymptomatic volunteers. Gastrointest Endosc (1986) 1.02
Stimulation of gastrin secretion from the perfused rat stomach by somatostatin antiserum. Life Sci (1979) 0.99
Intraluminal fungal colonization of gastrostomy tubes. Gastrointest Endosc (1993) 0.97
Cholinergic and peptidergic receptors on isolated human antral smooth muscle cells. Gastroenterology (1982) 0.95
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. J Rheumatol (2000) 0.94
Effect of SC-29333, an inhibitor of gastric secretion, on canine gastric mucosal blood flow and serum gastrin levels. Arch Int Pharmacodyn Ther (1978) 0.87
Prevalence and cost of hospitalization for gastrointestinal complications related to peptic ulcers with bleeding or perforation: comparison of two national databases. Am J Manag Care (1998) 0.87
The pharmacology of SC-27166: a novel antidiarrheal agent. J Pharmacol Exp Ther (1977) 0.87
Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study. Dig Dis Sci (1985) 0.87
3,3-Diphenyl-3-(2-alkyl-1,3,4-oxadiazol-5-yl)propylcycloalkylamines, a novel series of antidiarrheal agents. J Med Chem (1976) 0.86
Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals. Prostaglandins (1975) 0.86
Neural release of vasoactive intestinal peptide from the gut. Gastroenterology (1980) 0.85
Intestinal obstruction due to acute pancreatitis. Case report and review of literature. Am J Dig Dis (1974) 0.85
Stimulation of gastrin secretion in vitro by intraluminal chemicals: regulation by intramural cholinergic and noncholinergic neurons. Gastroenterology (1984) 0.85
Inhibition of intestinal secretion in the dog: a new approach for the management of diarrheal states. J Pharmacol Exp Ther (1981) 0.85
Prostaglandins: an overview of the worldwide clinical experience. J Assoc Acad Minor Phys (1991) 0.84
Comparative cytoprotective effects against alcohol insult. Misoprostol versus cimetidine. Dig Dis Sci (1986) 0.84
Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol (1995) 0.83
common duct obstruction in patients with intractable pain of chronic pancreatitis. Am Surg (1982) 0.82
Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas. Gastroenterology (1997) 0.82
Idiopathic esophageal ulceration in acquired immunodeficiency syndrome: successful treatment with misoprostol and viscous lidocaine. Am J Gastroenterol (1998) 0.82
Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man. Dig Dis Sci (1988) 0.81
Inhibition of neurally mediated gastrin secretion by bombesin antiserum. Am J Physiol (1985) 0.81
Identical patterns of somatostatin secretion from isolated antrum and fundus of rat stomach. Am J Physiol (1988) 0.81
Is peptic ulcer a prostaglandin deficiency disease? Hum Pathol (1986) 0.81
Effects of E prostaglandins, diphenoxylate and morphine on intestinal motility in vivo. Eur J Pharmacol (1975) 0.80
Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update. J Physiol Pharmacol (1995) 0.80
Impedance planimetric characterization of the distal oesophagus in the Goettingen minipig. J Biomech (1996) 0.80
Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha. Dig Dis Sci (1991) 0.79
Colonic involvement in salmonellosis. Dig Dis Sci (1979) 0.79
Apnea and cardiopulmonary arrest during and after endoscopy. J Clin Gastroenterol (1992) 0.78
Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview. Dig Dis Sci (1985) 0.78
[Raised trypsin concentration in duodenal secretion after a test meal (Lundh test) (author's transl)]. Dtsch Med Wochenschr (1975) 0.78
Biomechanical properties of the oesophagus damaged by endoscopic sclerotherapy. An impedance planimetric study in minipigs. Scand J Gastroenterol (1994) 0.78
Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy. J Endocrinol (1995) 0.78
Treatment of pyoderma gangrenosum with disodium cromoglycate. Dig Dis Sci (1984) 0.78
Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs. Dig Dis Sci (1994) 0.78
Effects of vasoactive intestinal peptide and secretin on gastrin and somatostatin secretion in the perfused rat stomach. Gastroenterology (1984) 0.78
Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer. Dig Dis Sci (1986) 0.77
Gastric antisecretory actions of (15S)-15-methyl prostaglandin E2 methyl ester and natural prostaglandin E2 in rhesus monkeys. Prostaglandins (1976) 0.77
Chronic systemic treatment with epidermal growth factor induces hypergastrinaemia in Goettingen minipigs. Scand J Gastroenterol (1995) 0.77
Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. Int J Clin Pharmacol Res (1989) 0.77
Refractory peptic ulcers. J Assoc Acad Minor Phys (1992) 0.77
Gastrointestinal toxicity of over-the-counter analgesics. Am J Gastroenterol (1998) 0.77
Misoprostol prevents damage to the gastric mucosa by stabilizing the mast cells. Prostaglandins (1987) 0.77
Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats. Dig Dis Sci (1995) 0.76
Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage. A double-blind endoscopic study in human subjects. Gastrointest Endosc (1986) 0.76
Immunoreactive somatostatin in human pancreatic secretion. J Clin Endocrinol Metab (1981) 0.76
Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1977) 0.76
Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs. Dig Dis (1995) 0.76
Epidermal growth factor attenuates the sclerotherapy-induced biomechanical properties of the oesophagus. An experimental study in minipigs. Scand J Gastroenterol (1995) 0.76
Synthesis and gastric antisecretory properties of 15-deoxy-16-hydroxyprostaglandin E analogues. J Med Chem (1977) 0.75
Omega-3 fatty acids and bowel cancer. Gastroenterology (1993) 0.75
Chlorpropamide-induced haemolytic anaemia. Postgrad Med J (1981) 0.75
Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury? Am J Gastroenterol (1996) 0.75
Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa. Clin Invest Med (1987) 0.75
Effect of oral and intravenous propantheline bromide on pentagastrin-stimulated canine gastric secretion. Arch Int Pharmacodyn Ther (1978) 0.75
Metiamide therapy of bleeding peptic ulcer during chronic hemodialysis. Am J Dig Dis (1977) 0.75
Gastric antisecretory effects of propantheline bromide and metiamide in rhesus monkeys. Arch Int Pharmacodyn Ther (1978) 0.75
Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury. Int J Clin Pharmacol Res (1989) 0.75
HIV-1 gp41 antigen demonstration in esophageal ulcers with acquired immunodeficiency syndrome. J Clin Gastroenterol (1991) 0.75
Nonsteroidal anti-inflammatory drugs and acute upper gastrointestinal bleeding: a prospective study. J Assoc Acad Minor Phys (1991) 0.75
Systemic treatment with epidermal growth factor induces anaemia in Goettingen minipigs. Clin Sci (Lond) (1995) 0.75
Preventive effects of recombinant human epidermal growth factor on the oesophageal epithelium in pigs subjected to sclerotherapy. Eur J Gastroenterol Hepatol (1995) 0.75
Update on acid-peptic disorders. J Assoc Acad Minor Phys (1992) 0.75
Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs. J Assoc Acad Minor Phys (1992) 0.75
Ureteric growth in a Goettingen minipig induced by epidermal growth factor. A case report. Scand J Urol Nephrol Suppl (1995) 0.75
Selective COX-2 inhibitors and gastrointestinal mucosal injury: pharmacological and therapeutic considerations. J Assoc Acad Minor Phys (2000) 0.75
Naloxone reversal of drug-induced diarrhea in mice. Arch Int Pharmacodyn Ther (1979) 0.75
Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats. Arch Int Pharmacodyn Ther (1979) 0.75
Future treatment of peptic ulcer: is there room for anti-infective drugs? J Physiol Pharmacol (1993) 0.75
Synergistic actions of propantheline bromide with cimetidine and thiopropazate hydrochloride in the prevention of stress ulcer formation in rats. J Pharmacol Exp Ther (1979) 0.75
Chronic administration of epidermal growth factor to pigs induces growth, especially of the urinary tract with accumulation of epithelial glycoconjugates. Lab Invest (1995) 0.75
The effects of aging on schizophrenic and mentally defective patients: visual, auditory, and grip strength measurements. J Gerontol (1971) 0.75
Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage. J Rheumatol Suppl (1990) 0.75
Antiulcer drugs and gastric mucosal integrity. Effects of misoprostol, 16,16-dimethyl PGE2, and cimetidine on hemodynamics and metabolic rate in canine gastric mucosa. Dig Dis Sci (1992) 0.75
Canine gastrointestinal motility effects of prostaglandin F2 alpha in vivo. Arch Int Pharmacodyn Ther (1979) 0.75
Synthesis and gastric antisecretory properties of 4,5-unsaturated derivatives of 15-deoxy-16-hydroxy-16-methylprostaglandin E1. J Med Chem (1983) 0.75